Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco ...

Phillips Medisize adds market-leading inhalation capabilities to its existing suite of drug delivery device design and ...

Expands Phillips Medisize’s inhalation drug delivery capabilities.

Phillips Medisize parent company Molex has completed its acquisition of Vectura from a subsidiary of cigarette maker Philip ...